HTFL Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

27.880

Open

27.450

VWAP

27.28

Vol

1.38M

Mkt Cap

2.35B

Low

26.660

Amount

37.58M

EV/EBITDA(TTM)

--

Total Shares

86.24M

EV

2.18B

EV/OCF(TTM)

--

P/S(TTM)

10.65

HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

Show More

Events Timeline

(ET)

2026-06-30

12:30:00

Heartflow Shares Drop 17% to $28.93

2026-06-30

10:30:00

Heartflow Shares Down 11.3%

2026-05-14 (ET)

2026-05-14

16:20:00

Heartflow Reports Q1 Revenue of $52.59M, Beating Expectations

2026-05-14

16:20:00

FY26 Gross Margin View Narrowed to 81%

2026-04-13 (ET)

2026-04-13

09:10:00

Heartflow Sues Cleerly for Patent Infringement in Texas

News

NASDAQ.COM

07-04NASDAQ.COM

Investment Comparison: Heartflow vs Iovance

Fool

Evaluating AI and Personalized Cell Therapy Investment Opportunities

Fool

Investment Choices Between HeartFlow and NovoCure: Diagnostics vs. Therapeutics

Newsfilter

06-16Newsfilter

Ventripoint Joins Global Congenital Heart Disease Alliance to Enhance Care Access

NASDAQ.COM

05-31NASDAQ.COM

Intrepid Family Office Acquires HeartFlow Shares

Fool

Intrepid Family Office Acquires HeartFlow Shares

5 Analyst Rating

Wall Street analysts forecast HTFL stock price to rise

4 Buy

1 Hold

0 Sell

Strong Buy

Current: 0.000

Low

35.00

Averages

38.60

High

40.00

Current: 0.000

Low

35.00

Averages

38.60

High

40.00

Freedom Capital

analyst

initiated

$37

AI Analysis

2026-06-30

Reason

Freedom Capital

analyst

Price Target

$37

AI Analysis

2026-06-30

initiated

Reason

Freedom Capital initiated coverage of Heartflow with a Buy rating and $37 price target. Healthcare AI is one of the fastest-growing technology segments, says the analyst, who found that the majority of generative AI spend in healthcare is flowing to startups rather than large incumbent HCIT companies. HeartFlow is one of the most widely adopted imaging AI solutions, specializing in coronary artery disease diagnosis, risk stratification, and treatment planning. Its AI-powered platform, Heartflow One, integrates with coronary CT angiography to create dynamic, personalized 3D models of the heart, the analyst tells investors.

Canaccord

Buy

downgrade

$43 -> $37

2026-05-15

Reason

Canaccord

Price Target

$43 -> $37

2026-05-15

downgrade

Buy

Reason

Canaccord lowered the firm's price target on Heartflow to $37 from $43 and keeps a Buy rating on the shares. The firm said Heartflow reported a solid beat-and-raise, with guidance reflecting the strong momentum the company is seeing. Canaccord said despite raising our revenue estimates, they are lowering their target due to the decline in the comp group multiple as the sector remains under pressure.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for HTFL

Unlock Now

Valuation Metrics

The current forward P/E ratio for Heartflow Inc (HTFL.O) is 0.00, compared to its 5-year average forward P/E of -53.73. For a more detailed relative valuation and DCF analysis to assess Heartflow Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

-53.73

Current PE

0.00

Overvalued PE

-44.01

Undervalued PE

-63.45

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

-40.78

Current EV/EBITDA

-21.41

Overvalued EV/EBITDA

-19.02

Undervalued EV/EBITDA

-62.55

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

11.02

Current PS

8.27

Overvalued PS

14.02

Undervalued PS

8.03

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

stock for buy and sell today

Intellectia · 241 candidates

Market Cap: >= 500.00MPrice: $3.00 - $200.00Price Change Pct: $-50.00 - $-1.00Monthly Average Dollar Volume: >= 500,000

Ticker

Name

Market Cap$

Bright Horizons Family Solutions Inc

4.63B

Upstream Bio Inc

691.69M

Pinterest Inc

12.52B

Fortune Brands Innovations Inc

7.48B

Draftkings Inc

22.41B

Rich Sparkle Holdings Ltd

778.75M

US MARKETS , ALL SECTORS

Intellectia · 158 candidates

Dividend Yield Ttm: >= 0Debt Equity: <= 1Pe Ttm: <= 10

Ticker

Name

Market Cap$

QXO Inc

15.83B

Bitmine Immersion Technologies Inc

13.35B

CG Oncology Inc

4.61B

SoundHound AI Inc

4.46B

Arcellx Inc

3.98B

Cal-Maine Foods Inc

3.79B

Whales Holding HTFL

Summit Partners Public Asset Management, LLC

Trading Trends

People Also Watch

Frequently Asked Questions

What is Heartflow Inc (HTFL) stock price today?

The current price of HTFL is 27.29 USD — it has increased 0.66

What is Heartflow Inc (HTFL)'s business?

HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

What is the price predicton of HTFL Stock?

Wall Street analysts forecast HTFL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HTFL is38.60 USD with a low forecast of 35.00 USD and a high forecast of 40.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Heartflow Inc (HTFL)'s revenue for the last quarter?

Heartflow Inc revenue for the last quarter amounts to 52.59M USD, increased 41.34

What is Heartflow Inc (HTFL)'s earnings per share (EPS) for the last quarter?

Heartflow Inc. EPS for the last quarter amounts to -0.32 USD, decreased -20.00

How many employees does Heartflow Inc (HTFL). have?

Heartflow Inc (HTFL) has 843 emplpoyees as of July 08 2026.

What is Heartflow Inc (HTFL) market cap?

Today HTFL has the market capitalization of 2.35B USD.